Available to sourceHuman Prescription DrugGastrointestinal

Sodium Phosphates

Active ingredients · Sodium Phosphate Dibasic Anhydrous, Sodium Phosphate Monobasic Monohydrate

142 mg/mL / 276 mg/mL · Injection Solution

By Fresenius Kabi USA, LLC

NDC: 63323-884
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: ANDA

Package sizes

25 VIAL, SINGLE-DOSE in 1 TRAY (63323-884-06) / 5 mL in 1 VIAL, SINGLE-DOSE (63323-884-01)NDC 63323-884-06Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.